What Can We Expect from Value-Based Funding of Medicines? A Retrospective Study
Abstract
Deciding on public funding for pharmaceuticals on the basis of value for money is now widespread. We suggest that evidence-based assessment of value has restricted the availability of medicines in Australia in a way that reflects the relative bargaining power of government and the pharmaceutical industry. We propose a simple informal game-theoretic model of bargaining between the funding agency and industry and test its predictions using a...
Paper Details
Title
What Can We Expect from Value-Based Funding of Medicines? A Retrospective Study
Published Date
Nov 26, 2015
Journal
Volume
34
Issue
4
Pages
393 - 402
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History